23
total announcements
GKSL.NS · 15 min delayed
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about Copy of Newspaper Publication about mailing Annual report
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about Pre advertisement for Notice of 7th AGM.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about attending GIA Healthcare Day with investors/analysts on August 31st, 2026. The meeting will be physical and will refer to publicly available documents for discussions.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Outcome of Board Meeting held on August 24, 2026. The Board has appointed Mrs. (Dr) Disha Bharpoda as Additional Non-Executive Independent Director with effect from August 24, 2026. The details as required under Regulation 30 of the Listing Regulations are enclosed as Annexure A.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding the appointment of Mrs. Disha Bharpoda as an Additional Non-Executive Independent Director, subject to shareholder approval at the next Annual General Meeting.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding the appointment of Mrs Disha Bharpoda as a Non-Executive Independent Director of the company, effective August 24, 2026.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has announced its unaudited financial results for the quarter ended June 2026, with the independent auditor's review report indicating no material misstatement.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with the independent auditor's review report indicating no material misstatements.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about the change in management, appointing Mr. Paresh Dhoti as an Additional Non-Executive Independent Director.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, stating that there was no deviation in the utilization of proceeds of IPO from the objects stated in the Red Herring Prospectus dated December 4, 2025, for the quarter ended June 30, 2026.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney and Super Speciality Limited has submitted its third Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI ICDR Regulations, 2018. The report confirms that the funds raised through the Fresh Issue of Equity Shares aggregating to Rs. 250.80 Crore have been utilized for the intended objects of the issue.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has responded to a clarification request from the National Stock Exchange regarding the company's financial results for the quarter ended 30-Sep-2025. The company has paid a penalty for delayed submission of financial results and has corrected discrepancies in the XBRL utility.
Gujarat Kidney And Super Speciality Limited
The NSE has sought clarification from Gujarat Kidney And Super Speciality Limited regarding its financial results for the quarter ended 30-Sep-2025 under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has been asked to respond to specific queries.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Notice of Postal Ballot.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding the appointment of Mr. Paresh Dhoti as a Non-Executive Non-Independent Director, with the process being completed recently due to technical glitches.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has clarified a deficiency observation in its financial results for the quarter ended 31-Mar-2026, stating that the date mentioned for signing of the standalone financial statements was incorrect due to a typographical error. The company has undertaken to publish the corrected financial statements on its website and assured the exchange of its continued compliance with SEBI LODR Regulations.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, regarding shares dematerialised during the quarter ended on June 30, 2026.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about Acquisition of 51% of Blue Tree Clinics LLC, a polyclinic duly licensed in Dubai, United Arab Emirates. The acquisition is for expansion of existing business in new geography with a set of services other than that of provided by the company in India. The consideration shall be paid in 2 tranches, with a maximum time required of 50 days. The cost of acquisition is Rs 19,83,64,500/-.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding the appointment of Mr. (Dr) Paresh Dhoti as Non-Executive Independent Director of the company, effective July 09, 2026. The company also announced the acquisition of a 51% stake in Blue Tree Clinics LLC, UAE, and the conduct of a postal ballot for seeking approval of the shareholders for variation in the objects of the IPO.